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Abstract
Nonstructural protein 4B (NS4B) is a key organizer of hepatitis C virus (HCV) replication complex formation. In concert with
other nonstructural proteins, it induces a specific membrane rearrangement, designated as membranous web, which serves
as a scaffold for the HCV replicase. The N-terminal part of NS4B comprises a predicted and a structurally resolved
amphipathic a-helix, designated as AH1 and AH2, respectively. Here, we report a detailed structure-function analysis of
NS4B AH1. Circular dichroism and nuclear magnetic resonance structural analyses revealed that AH1 folds into an
amphipathic a-helix extending from NS4B amino acid 4 to 32, with positively charged residues flanking the helix. These
residues are conserved among hepaciviruses. Mutagenesis and selection of pseudorevertants revealed an important role of
these residues in RNA replication by affecting the biogenesis of double-membrane vesicles making up the membranous
web. Moreover, alanine substitution of conserved acidic residues on the hydrophilic side of the helix reduced infectivity
without significantly affecting RNA replication, indicating that AH1 is also involved in virus production. Selective membrane
permeabilization and immunofluorescence microscopy analyses of a functional replicon harboring an epitope tag between
NS4B AH1 and AH2 revealed a dual membrane topology of the N-terminal part of NS4B during HCV RNA replication.
Luminal translocation was unaffected by the mutations introduced into AH1, but was abrogated by mutations introduced
into AH2. In conclusion, our study reports the three-dimensional structure of AH1 from HCV NS4B, and highlights the
importance of positively charged amino acid residues flanking this amphipathic a-helix in membranous web formation and
RNA replication. In addition, we demonstrate that AH1 possesses a dual role in RNA replication and virus production,
potentially governed by different topologies of the N-terminal part of NS4B.
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Introduction
Hepatitis C virus (HCV) infection is a leading cause of chronic
hepatitis, liver cirrhosis and hepatocellular carcinoma worldwide,
with a peak of the disease burden expected in around 10 years
from now [1]. HCV and GB virus B have been classified in the
Hepacivirus genus within the Flaviviridae family, which also
includes the genera Flavivirus, Pestivirus and Pegivirus [2].
Additional closely related viruses have been identified recently in
horses as well as other animal species, and have been classified in
the Hepacivirus and Pegivirus genera, including nonprimate
hepaciviruses (NPHV) [3,4].
HCV contains a 9.6-kb positive-strand RNA genome encoding
a polyprotein precursor that is co- and posttranslationally
processed into ten structural and nonstructural proteins [2,5]. As
all positive-strand RNA viruses, HCV replicates its genome in a
membrane-associated replication complex composed of viral
proteins, replicating RNA, rearranged intracellular membranes
and additional host factors [6,7,8,9]. The specific membrane
alteration induced during HCV RNA replication has been
designated as membranous web [10,11]. Nonstructural proteins
3 through 5B are essential for HCV RNA replication, and their
functional complex is referred to as replicase.
Nonstructural protein 4B (NS4B) is the least characterized HCV
protein. However, evidence from biochemical, structural and
genetic studies as well as electron microscopy (EM) indicates that
NS4B is a key organizer of HCV replication complex formation
(reviewed in [12]). Indeed, NS4B has been shown to induce
formation of the membranous web which serves as a scaffold for
the viral replicase [10,11]. More recent work has shown that the
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other nonstructural proteins, especially NS5A, contribute to the
formation of double membrane vesicles (DMVs) which make up
the membranous web [13] and are believed to represent sites of
HCV RNA replication [14].
NS4B is a 27-kDa integral membrane protein comprising an N-
terminal part (amino acids [aa] 1 to ,69), a central part harboring
four predicted transmembrane segments (aa ,70 to ,190), and a
C-terminal part (aa ,191 to 261). The N-terminal part comprises
a predicted and a structurally resolved amphipathic a-helix,
designated as AH1 and AH2, respectively. AH2 comprises aa 42–
66 and has been shown to play an important role in HCV RNA
replication [15]. Intriguingly, it has the potential to traverse the
phospholipid bilayer as a transmembrane segment, likely upon
oligomerization [15,16,17,18]. Hence, the N-terminal part of
NS4B may adopt a dual cytosolic and ER luminal topology.
However, this has not been explored in a functional, replicative
context.
AH1 was predicted as an amphipathic a-helix and reported to
mediate membrane association and HCV RNA replication [19].
However, membrane association of AH1 is debated [12] and the
actual structure as well as detailed functional analyses, covering
the complete HCV life cycle, have not been reported.
Here, we describe the three-dimensional structure of AH1 and
provide a detailed structure-function analysis, indicating that this
structurally highly conserved segment of NS4B possesses a dual
role in HCV RNA replication and virus production. In addition,
we demonstrate that the N-terminal part of NS4B adopts a dual
membrane topology in an authentic replication context, allowing
to speculate that the different functions of NS4B may be governed
by different topologies.
Results
Sequence analyses and structure predictions
Sequence analyses and structure predictions were performed to
assess the degree of conservation of the N-terminal part of NS4B
and to identify potential structural determinants. The degree of aa
conservation among different genotypes was investigated by
ClustalW alignment of 27 reference sequences representative of
the major HCV genotypes and subtypes. This alignment revealed
that the segment comprising aa 50–70, including part of
amphipathic a-helix AH2 (aa 42–69), is well conserved, whereas
the aa 1–50 segment, including predicted amphipathic a-helix
AH1, appears highly variable except for a few well-conserved
positions (e.g., basic residues at positions 18 and 20 and a proline
at position 38 (Fig. 1). However, the apparent variability is limited
at most positions since the observed residues exhibit similar
physicochemical properties, as indicated both by the similarity
pattern (colons and dots) and the hydropathic pattern, where o, i,
and n denote hydrophobic, hydrophilic, and neutral residues,
respectively (see Legend to Figure 1 for details). Moreover, all
secondary structure prediction methods indicate the presence of an
a-helix in the segment comprising aa 5–35 in all genotypes.
Hence, despite the apparent aa variability, conservation of the
hydropathic pattern suggests that the overall structure of AH1 is
conserved.
While AH2 was predicted and subsequently shown to associate
with membranes, the N-terminal aa 1–40 segment does not show
propensity to partition into a phospholipid bilayer [15]. This is in
agreement with an analysis by Palomares-Jerez et al. [20] but in
contrast to an earlier report by Elazar et al. [19] (see Discussion
section).
Structure of NS4B AH1
To gain insight into the structure and potential lipotropic
properties of the NS4B aa 1–40 segment, the corresponding
peptide derived from the HCV JFH1 strain (genotype 2a),
designated as NS4B[1–40], was chemically synthesized, purified,
and analyzed by circular dichroism (CD) and nuclear magnetic
resonance (NMR).
The secondary structure of NS4B[1–40] was examined by CD
spectroscopy in various membrane mimetic media, including the
lysolipid L-a-lysophosphatidylcholine (LPC), detergents (sodium
dodecyl sulfate [SDS], n-dodecyl-b-D-maltoside [DDM], dode-
cylphosphocholine [DPC]), or co-solvents (2,2,2-trifluoroethanol
[TFE]-water mixture) (Fig. 2A). In all cases, the CD spectra
displayed the typical shape of an a-helix with two minima at 208
and 222 nm and one maximum around 192 nm. CD deconvolu-
tion indicated a similar a-helix content of 75610%, although a
weaker signal intensity was observed in the presence of DDM.
These results indicate the high propensity of NS4B[1–40] to adopt
an a-helical structure in a hydrophobic environment. Interestingly,
the peptide solubilized in water displayed a complex spectrum
with a weak maximum around 188 nm and two broad minima
around 202 and 222 nm, indicating the presence of a mixture of a-
helical and random structures. Accordingly, an a-helix content of
approximately 22% together with 55% disordered structure was
estimated with the various CD deconvolution methods used. Such
a secondary structure content for a short peptide suggests that it
possibly exists as soluble, micelle-like aggregates which stabilize
some residual a-helical folding in aqueous solution through the
formation of a hydrophobic core by the hydrophobic sides of
several peptide monomers.
As samples of NS4B[1–40] prepared in deuterated micellar SDS
and DPC displayed poorly resolved NMR spectra, the three-
dimensional structure of the peptide was determined in 50% TFE-
d2 which exhibits a CD spectrum comparable to those observed in
LPC, SDS and DPC (Fig. 2A) and yielded well-resolved NMR
spectra. Sequential assignment of all spin systems was completed
and an overview of the sequential and medium-range nuclear
Overhauser enhancement (NOE) connectivities is shown in
Figure 2B. The NOE connectivity patterns demonstrated that
the central part of the peptide, including residues 4–32, displays
most characteristics of an a-helix, including strong dNN(i,i+1) and
medium daN(i,i+1) sequential connectivities as well as weak
daN(i,i+2), medium or strong daN(i,i+3) and dab(i,i+3), as well as
weak daN(i,i+4) medium-range connectivities. Apart from this
central a-helix, some rare connectivities of weaker intensity are
present in both termini of the peptide as a sign of highly flexible
Author Summary
With an estimated 180 million chronically infected individ-
uals, hepatitis C virus (HCV) is a leading cause of chronic
hepatitis, liver cirrhosis and hepatocellular carcinoma
worldwide. HCV is a positive-strand RNA virus that builds
its replication complex on rearranged intracellular mem-
branes, designated as membranous web. HCV nonstruc-
tural protein 4B (NS4B) is a key organizer of HCV
membranous web and replication complex formation.
Here, we provide a detailed structure-function analysis of
an N-terminal amphipathic a-helix of NS4B, named AH1,
and demonstrate that it plays key roles in shaping the
membranous web as well as in virus production. We also
show that the N-terminal part of NS4B adopts a dual
membrane topology in a replicative context, possibly
reflecting the different roles of this protein in the viral life
cycle.
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unstructured ends. The NOE-based indications of an a-helical fold
were supported by the deviation of the 1Ha and 13Ca chemical
shifts from random coil values [21] (Fig. 2C). A series of
continuous negative variations of 1Ha chemical shifts (Dd1Ha
,20.1 ppm) and positive variations of 13Ca chemical shifts
(Dd13Ca.0.07 ppm) observed for residues 3 to 32 are indeed
typical of an a-helical conformation. Based on the NOE-derived
inter-proton distance and dihedral angle constraints deduced from
chemical shifts, a set of 50 structures was calculated with X-
PLOR, and a final set of 37 low-energy structures that fully
satisfied the experimental NMR data were retained. The number
and types of NOE constraints used for the structure calculations as
well as the statistics for this final set of 37 structures are provided in
Table S1. All structures show a regular a-helical conformation
extending from residues 4 to 32. A superimposition of the
calculated structures is shown in Figure S1. As illustrated in
Figure 2D for the representative structure of NS4B[1–40], the
central part of the a-helix, including residues Ile 13 to Leu 25,
clearly exhibits an amphipathic character, with all hydrophobic
residues exposed on one side and charged as well as polar residues
on the opposite side. Interestingly, the a-helical folding of this
central segment appears to be particularly stable, as indicated by
the very slow amide proton exchange observed by NMR in this
region (Fig. 2B, blue squares). Hence, this segment likely
constitutes an important structural scaffold. In addition, the bulky
hydrophobic residues Leu 6 and Ile 7 are also located on the
hydrophobic side of the a-helix, suggesting that aa segment 6–25
may bind to a membrane hydrophobic core. These features
suggest that AH1 may interact with the membrane interface in an
in-plane topology, at least transiently. The C-terminal end (aa
residues 26–32) of the a-helix does not include any hydrophobic
residue but comprises an intriguingly large number of glutamine
residues, which are, however, not conserved in all HCV genotypes
(Fig. 1). Because of its purely hydrophilic nature, the folding of this
C-terminal part most likely depends on interactions with other
parts of NS4B and/or other interaction partners.
NS4B AH1 from different hepaciviruses share conserved
structural features
To investigate the structural conservation of AH1, we compared
two distantly related hepacivirus species, HCV and NPHV. As
shown in the upper part of Figure 3, there is only a low degree of
aa conservation between the NS4B aa 1–40 segments from the
HCV JFH1 strain and NPHV-B10-022 [3]. However, the latter
Figure 1. Sequence analysis of the N-terminal part of HCV NS4B. Multiple alignment of NS4B amino acid (aa) 1–70 sequences from
representative HCV strains of confirmed genotypes [66] are shown (http://euhcvdb.ibcp.fr; [41]). Genotype, GenBank accession number, and strain are
indicated for each sequence. Amino acids are numbered with respect to NS4B (top row). The consensus sequence (top row) was deduced from the
ClustalW multiple alignment of the indicated NS4B sequences [43]. To highlight the aa variability at each position, aa identical to the consensus
sequence are indicated by hyphens. The degree of aa physicochemical conservation at each position can be inferred from the similarity index
according to ClustalW convention (asterisk, invariant; colon, highly similar; dot, similar) [43] and the consensus hydropathic pattern: o, hydrophobic
position (Pro, Val, Leu, Ile, Met, Phe, Tyr, Trp); n, neutral position (Gly, Ala, Ser, Thr); i, hydrophilic position (Asn, Gln, Asp, Glu, His, Lys, Arg); v, variable
position (i.e. when both hydrophobic and hydrophilic residues are observed at a given position). To highlight the variable sequence positions in
NS4B, conserved hydrophilic and hydrophobic positions are highlighted in yellow and gray, respectively. Residues are color-coded according to the
Wimley and White hydrophobicity scales [67]: hydrophobic residues are black (Pro, Val, Leu, Ile, Met, Phe, Tyr, Trp); polar residues are orange (Gly, Ala,
Ser, Thr, Asn and Gln); positively and negatively charged groups of basic (His, Lys, Arg) and acidic residues (Glu, Asp) are blue and red, respectively.
Consensus secondary structure predictions of NS4B from representative HCV strains (Second. struct. cons.) are indicated as helical (h, blue) or
undetermined (coil [c], orange). Predictions were made by using the web-based algorithms SOPM, HNNC, DSC, GOR IV, PHD, Predator and SIMPA96
available at the NPSA website (http://npsa-pbil.ibcp.fr; [42] and refs. therein). NMR AH2 structure (bottom row) denotes the conformation of residues
determined previously by nuclear magnetic resonance (PDB entry 2JXF; [26]). Residue conformations are indicated as helical (H) or undetermined (C).
doi:10.1371/journal.ppat.1004501.g001
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Figure 2. Structure of NS4B AH1. (A) Far UV circular dichroism (CD) spectra of synthetic peptide NS4B[1–40] recorded in 5 mM sodium
phosphate pH 7.5 (H2O), complemented with either 50% 2,2,2-trifluoroethanol (TFE) or 1% L-a-lysophosphatidylcholine (LPC) or the following
detergents: 100 mM sodium dodecyl sulfate (SDS), 100 mM n-dodecyl-b-D-maltoside (DDM), or 100 mM dodecylphosphocholine (DPC). (B) Summary
of sequential (i, i+1) and medium-range (i, i+2 to i, i+4) nuclear Overhauser enhancements (NOEs) of NS4B[1–40] in 50% TFE. Sequential NOEs allowing
the assignment of proline residues are indicated in red. Asterisks indicate that the presence of a NOE cross peak was not confirmed because of
overlapping resonances or the lack of H assignment. Intensities of NOEs are indicated by the height of the bars. Amide protons that remained
observable in nuclear magnetic resonance (NMR) spectra after three days in 50% D20/50% deuterated TFE (TFE-d3) are indicated by blue squares
(slow exchangeable protons). (C) NMR-derived 1Ha and 13Ca chemical shift differences were calculated by subtraction of the experimental values
from the reported random coil conformation values in TFE [61]. The dashed lines indicate the standard threshold value of DHa (20.1 ppm) or DCa
(0.7 ppm) for an a-helix. (D) Representative NMR structure of NS4B[1–40] peptide in 50% TFE. The aa sequence of NS4B[1–40] is depicted in (a). The
box indicates a-helix residues. Residues are color-coded as described in the Legend to Figure 1. (b–d) representative NMR structure model of NS4B[1–
40] (PDB entry 2LVG) showing the amphipathic character of a-helix 4–32. b, ribbon representation of the side view colored as in panel a; c and d,
hydrophilic side and hydrophobic side views of the molecular surface of amphipathic a-helix 4–32. Figures were generated from structure
coordinates using VMD (http://www.ks.uiuc.edu/Research/vmd/) [68] and rendered with POV-Ray (http://www.povray.org/).
doi:10.1371/journal.ppat.1004501.g002
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was strongly predicted to adopt an a-helical fold by secondary
structure analyses performed as described in the Legend to
Figure 1. Based on these observations, a-helix projections
generated by Heliquest [22] were compared, as shown in the
lower part of Figure 3. Interestingly, despite divergent primary aa
sequences, a-helix projections showed a conservation of the
amphipathic character of AH1 and of a number of structurally
conserved features, including the presence of two positively
charged residues, i.e. arginine or lysine, flanking the helices at
the borders between the hydrophilic and hydrophobic sides as well
as the presence of two negatively charged glutamate residues
aligned on the hydrophilic side of AH1 from HCV and NPHV
(Fig. 3). Taken together, these observations highlight structurally
conserved features of AH1 from phylogenetically distant hepaci-
viruses, suggesting similar functions of this segment of NS4B
within the Hepacivirus genus.
The positively charged residues flanking AH1 are crucial
for HCV RNA replication
The role of the structurally conserved features of AH1 in HCV
RNA replication was investigated by the use of a subgenomic
JFH1 replicon harboring a luciferase reporter gene. As shown in
Figure 4A, alanine substitution of Lys 18 and Lys 20, either
simultaneously (K18A/K20A) or individually (K18A and K20A),
abrogated HCV RNA replication, as inferred by comparison with
the non-replicative DGDD polymerase mutant. In addition,
insertion of one alanine residue between Lys 18 and Ser 19
(KASK), resulting in a 110u twist of the a-helix and thus an altered
positioning of the two lysine residues in positions 18 and 20,
abrogated HCV RNA replication. Hence, the positively charged
residues flanking AH1 on either side are required for HCV RNA
replication. By contrast, alanine substitution of the two conserved
glutamate residues highlighted above (E8A/E15A) did only slightly
affect RNA replication at an early time point (about 5-fold
reduction in relative light units [RLU] at 24 h, but no appreciable
difference at 48 and 72 h).
To explore the mechanism by which substitution of the
positively charged aa residues affects HCV RNA replication, the
subcellular localization of NS4B harboring the different mutations
was investigated in Huh-7 cells using a T7 RNA polymerase-based
NS3-5B polyprotein expression system [23]. As shown in
Figure 4B, all mutants displayed a similar cytoplasmic, reticular
and dot-like distribution pattern, as described previously for NS4B
and corresponding to the typical localization on membranes of the
ER and of ER-derived modified membranes making up the
membranous web [11,15]. In addition, all mutants colocalized
with NS5A to the same extent as the wild-type. These observations
indicate that the replication defect of mutants K18A/K20A,
K18A and K20A cannot be explained by an aberrant subcellular
localization of NS4B or an obvious decrease in NS4B-NS5A
colocalization.
NS4B AH1 contributes to proper DMV formation
To gain deeper insight into the consequences of removal of the
positively charged residues flanking AH1, we investigated the
ultrastructure of membrane rearrangements induced by the
different NS4B mutants by EM. To this end, the mutants were
expressed in Huh-7 cells using a T7 RNA polymerase-based NS3-
5B polyprotein expression system, as above. Previous work had
shown that DMVs are formed in this system and that these closely
Figure 3. NS4B AH1 is structurally conserved among phylogenetically distant hepaciviruses. The sequences of NS4B amino acids (aa) 1–
70 from the HCV JFH1 strain (genotype 2a; UniProtKB entry Q99IB8) and the non primate hepacivirus strain NPHV-B10-022 (UniProtKB entry I1ZAS8)
were aligned by ClustalW (see Legend to Figure 1 for color code). The similarity index according to ClustalW convention is shown below (asterisk,
invariant; colon, highly similar; dot, similar). Helical wheel projections of aa 7–33 of HCV JFH1 and NPHV-B10-022 are shown in the lower panel. The
structurally conserved positively charged aa residues flanking the amphipathic a-helices (K, lysine; R, arginine) as well as the glutamate (E) residues on
the hydrophilic side are highlighted.
doi:10.1371/journal.ppat.1004501.g003
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resemble the HCV-induced membrane rearrangements observed
in the context of subgenomic RNA replication and HCV infection
[13,24]. As shown in Figure 5A, regular round-shaped DMVs
were readily observed for mutants K18A/K20A, K18A and K20A
but, strikingly, these exhibited a large increase in diameter as
compared to the ones formed by the wild-type construct. By
contrast, mutant E8A/E15A, which replicated almost as wild-type,
formed DMVs that were indistinguishable from wild-type.
Quantitation of the DMV diameter for each construct demon-
strated that DMVs formed by mutants K18A/K20A, K18A and
K20A were significantly larger than the ones formed by the wild-
type as well as by mutant E8A/E15A (Fig. 5B; see Figure Legend
for details). Taken together, these observations indicate that the
loss of one of the conserved positively charged residues flanking
AH1, i.e. Lys 18 and/or Lys 20, results in the formation of larger
DMVs that do not support HCV RNA replication.
Reverse genetics confirm a requirement for HCV RNA
replication of positively charged residues flanking NS4B
AH1
In order to further assess the importance of the positively
charged residues flanking AH1, mutations K18A, K20A and
K18A/K20A were introduced into a selectable subgenomic JFH1
replicon harboring a neomycin resistance cassette in the first
cistron. The corresponding in vitro transcribed RNAs were
electroporated into Huh-7.5 cells, followed by selection with
500 mg/ml G418 for 3 weeks. About 70 G418-resistant colonies
per mg of electroporated RNA were obtained for mutant K18A
whereas mutants K18A/K20A and K20A did not yield any viable
colonies. Total RNA was extracted from pooled colonies and the
NS3-5B region amplified by RT-PCR, followed by cloning of
amplicons and sequencing of 10 DNA subclones. Sequence
analyses revealed that the K18A mutation in AH1 was retained
in all clones. Amino acid changes identified elsewhere in the NS3-
5B region are listed in Table 1. Strikingly, mutation P189L in
domain I of NS5A was found in 9 out of 10 clones. The only clone
which did not harbor this aa change in NS5A showed a
substitution of Gln 26 by arginine (Q26R) in NS4B. Interestingly,
this mutation results in a new positively charged residue flanking
the hydrophobic side of AH1 (Fig. 3). Selection of a compensatory
positively charged residue flanking AH1 was also observed in
clones harboring pseudoreversions Q22R and Q27R, which
coexisted with the NS5A P189L change. The relevance of these
compensatory mutations was tested by reintroducing them, alone
or in combination with K18A, into a JFH1 subgenomic replicon
harboring a luciferase reporter gene. As shown in Figure 6A, the
NS5A P189L change alone did not confer any replication
advantage to the wild-type replicon and did only slightly (about
2-fold) improve replication of the NS4B K18A mutant. However,
the Q22R and Q26R changes in NS4B AH1 strongly enhanced
RNA replication capacity of mutant K18A (about 1.5 log for
Q22R and 1.0 log for Q26R). Remarkably, the addition of NS5A
change P189L to the NS4B K18A/Q22R mutant completely
rescued RNA replication, thereby supporting the notion of a
functional interaction between NS4B AH1 and NS5A. Finally, the
NS4B Q27R change, identified in one clone harboring a number
of additional aa changes (Table 1), did not rescue RNA replication
of mutant K18A.
Interestingly, modeling of pseudorevertants Q22R and Q26R in
the NMR structure of AH1 revealed that the lateral chains of the
two selected arginine residues are oriented to the same helix side as
the mutated lysine residue in position 18, opposite to Lys 20,
thereby restoring a positively charged residue flanking AH1 at
distances of one (Q22R) or two (Q26R) a-helix turns (Fig. 6B). By
contrast, the Q27R change, which was unable to rescue the
replication defect of mutant K18A when reintroduced alone,
results in a positively charged residue oriented to the opposite side
of Lys 18, i.e. to the same side as Lys 20, thereby failing to restore
a conserved feature of AH1. Taken together, selection of
pseudoreversions confirms the requirement for two positively
charged residues flanking AH1 on either side, as initially suggested
by their conservation throughout the different HCV genotypes as
well as the Hepacivirus genus (Fig. 3).
NS4B AH1 is involved in virus production
As mutant E8A/E15A did not show any significant replication
defect, we introduced these aa substitutions into a full-length Jc1
(J6/JFH1 chimeric) HCV genome and assessed virus production
by 50% tissue culture infective dose (TCID50) determination. As
shown in Figure 7A, infectious virus production by this mutant
was strongly reduced, with more than 100-fold lower extra- and
intracellular TCID50 yields as compared to the wild-type virus.
These results clearly indicate that NS4B AH1 possesses a role in
HCV particle production. Quantitation of intra- vs. extracellular
TCID50 suggests that the defect is primarily at the level of particle
assembly, but an effect on release cannot be excluded (Fig. 7A).
Quantitation of intra- vs. extracellular HCV RNA levels
demonstrates that mutant E8A/E15A replicates in a full-length
viral genome context and confirms the selective defect in virus
production of this mutant (Fig. 7B).
The N terminus of NS4B exhibits a dual topology in a
replicative context
As discussed in the Introduction section, the N terminus of
NS4B has previously been proposed to adopt a dual topology,
based on evidence from glycosylation acceptor site tagging
experiments performed in an in vitro translation system as well
as in transiently transfected mammalian cells [16,17]. In addition,
we had shown that AH2 has the potential to traverse the
phospholipid bilayer and that oligomerization of AH2 is likely
required for this process [15,18]. However, the membrane
topology of the N-terminal part of NS4B, comprising AH1 and
AH2, has not been investigated in a functional, replicative context.
Hence, we took advantage of a recently developed JFH1
subgenomic replicon harboring an HA epitope tag insertion after
NS4B aa position 38, i.e. between AH1 and AH2 [14], and
Figure 4. The conserved positively charged amino acids in NS4B AH1 are essential for RNA replication. (A) AH1 mutants introduced
into a subgenomic replicon construct harboring a firefly luciferase reporter gene were analyzed in Huh-7.5 cells by luciferase activity measurement at
4, 24, 48 and 72 h post-electroporation of in vitro transcribed RNA. Relative light units (RLU) were normalized to values measured at 4 h. DGDD
represents a replication-deficient control with an inactivating deletion in the RNA-dependent RNA polymerase active site. Results from a
representative experiment performed in triplicate are shown. (B) Alanine substitution of the conserved positively charged amino acids in AH1 does
not alter the subcellular localization of NS4B. T7 RNA polymerase-driven N3-5B polyprotein expression constructs harboring the different NS4B
mutations were transfected into H7-T7-IZ cells which constitutively express the T7 polymerase, followed by immunofluorescence analyses as
described in the Materials and Methods section. Polyclonal antibody #86 against NS4B and monoclonal antibody 9E10 against NS5A, were used as
primary antibodies.
doi:10.1371/journal.ppat.1004501.g004
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examined the topology of the epitope tag by selective membrane
permeabilization and immunofluorescence analyses.
In a series of preliminary experiments, we found that incubation
of fixed cells with 0.05% digitonin for 15 min at 4uC allowed for
selective permeabilization of the plasma membrane but not the
endoplasmic reticulum (ER) membrane of Huh7-Lunet cells which
are highly permissive for HCV replication [25]. By contrast, 0.2%
digitonin under the same experimental conditions permeabilized
both membrane compartments. As shown in Figure 8A, the
cytosolically oriented core and NS5A proteins could be detected at
the same fluorescence intensity under both selective and total
permeabilization conditions while the ER luminally oriented E1
glycoprotein could be detected only after total membrane
permeabilization. Interestingly, the HA tag inserted between
NS4B AH1 and AH2 was consistently detected at an approxi-
mately 50% reduced fluorescence intensity under selective as
opposed to total membrane permeabilization conditions (Fig. 8A
and 8B). These results, which were independent from the choice of
anti-HA antibody, indicate a dual topology of the HA tag and,
thereby, of the N-terminal part of NS4B in a functional, replicative
context.
To investigate whether the AH1 mutations described and
characterized above affect the membrane topology of the N-
terminal part of NS4B, we introduced mutations K18A/K20A
and E8A/E15A into a T7 RNA polymerase-driven construct
allowing the expression of NS3-5B including NS4B harboring the
HA tag between AH1 and AH2. As shown in Figure 8C and
Figure S2, and consistent with the results obtained in a replicative
context, the fluorescence intensity for HA tag detection was
reduced by about 50% under selective as compared to total
membrane permeabilization conditions. Mutations K18A/K20A
and E8A/E15A did not affect this ratio. By contrast, a previously
described AH2 mutant which is unable to associate with
membranes, oligomerize and traverse the phospholipid bilayer,
designated as AH2mut [15,18], was detected at equal fluorescence
intensity under both selective and total permeabilization condi-
tions. This additional control validates our selective permeabiliza-
tion analyses, confirming that the N-terminal part of NS4B adopts
a dual topology in an authentic replication context as well as in the
context of heterologous NS3-5B expression and is unaffected by
mutations K18A/K20A and E8A/E15A which abrogate HCV
RNA replication and strongly reduce virus production, respec-
tively.
Discussion
In the present study, we report the three-dimensional structure
of NS4B AH1 and provide a detailed structure-function analysis of
this N-terminal amphipathic a-helix. We show that AH1 folds as
an a-helix extending from aa 4 to 32 and propose that the fold as
well as a number of key structural features are conserved across
hepaciviruses. Site-directed mutagenesis and reverse genetics
revealed that the conserved positively charged aa residues 18
and 20 flanking AH1 on either helix side are essential for HCV
RNA replication. EM analyses demonstrated that these residues
play a crucial role in determining the correct size of the DMVs
making up the membranous web. Furthermore, the conserved
acidic residues 8 and 15 on the hydrophilic side of AH1 were
found to be involved in virus production, likely at the level of
assembly. Hence, NS4B AH1 possesses a dual role in HCV RNA
Figure 5. Mutations of the conserved positively charged amino
acids in NS4B AH1 affect the morphology of double-membrane
vesicles. (A) Electron microscopy (EM) analyses of H7-T7-IZ cells
transfected with empty vector (mock) or T7 RNA polymerase-driven N3-
5B polyprotein expression constructs harboring wild-type (wt) or
mutant NS4B. Cells were fixed 24 h post-transfection and processed
for EM as described in the Materials and Methods section. The scale bar
corresponds to 500 nm. Note that double-membrane vesicles (DMV)
induced by mutants K18A, K20A and K18A/K20A are larger as compared
to wt and E8A/E15A. (B) Graphical representation of DMV diameter
induced by wt and NS4B mutants. The analysis is based on at least 621
DMVs from at least 10 different transfected cells. Mean value 6 SEM for
wt = 178 .463 .1 nm (n = 666) ; K18A = 298 .365 .1 (n = 832) ;
K20A=295.165.0 (n = 621); K18A/K20A= 374.065.0 (n = 1317). Horizon-
tal lines (red) indicate mean values. * P#0.0001; ns, non significant (P.
0.25).
doi:10.1371/journal.ppat.1004501.g005
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replication and virus production. Finally, an HCV replicon
harboring an epitope tag between AH1 and AH2 allowed to
study the topology of the N-terminal part of NS4B in a functional
context. Our findings obtained by selective membrane permeabi-
lization and immunofluorescence analyses indicate that this part of
NS4B adopts a dual membrane topology in an authentic
replication context, likely determined by partial translocation of
AH2 across the membrane.
Although AH1 of NS4B is globally amphipathic, NMR
analyses revealed that the central amphipathic region compris-
ing aa 13–25 is particularly stable and likely constitutes an
important structural scaffold. Together with N-terminal hydro-
phobic residues Leu 6 and Ile 7, it might interact with the
membrane interface in an in-plane topology, at least transiently.
Such a binding might also allow stabilization of the a-helical
fold of the hydrophilic C-terminal part comprising aa 26–32
upon interaction with the membrane. However, the highly
hydrophilic character of this latter part suggests that it may
adopt alternative conformations, possibly upon interaction with
other parts of NS4B and/or other interaction partners. In
addition, the overall hydrophilic character of AH1 is compatible
with the absence of direct membrane association per se, as
reported previously [15], and suggests that this a-helix may be
involved in alternative intra- and/or inter-molecular interac-
tions, e.g. with NS5A (see below).
The present work complements the structures of NS4B AH2
[15], H1 (RM and FP, unpublished) and H2 [26]. AH2 represents
an amphipathic a-helix spanning aa 42 to 66 and H2 a ‘‘twisted’’
amphipathic a-helix extending from aa 229 to 253. Although
AH1, AH2 and H2 share amphipathic character and play critical
roles in HCV RNA replication, their structures are very different.
AH1 is mainly hydrophilic, possesses a limited hydrophobic side
lacking aromatic residues and is flanked by conserved positively
charged residues, AH2 has a very hydrophobic side including 6
highly conserved aromatic residues, and H2 represents a ‘‘twisted’’
amphipathic a-helix. Future work will have to address the
structure of the central part of NS4B believed to harbor four
transmembrane segments and the ultimate goal will be to solve a
complete structure of this integral membrane protein.
Our mutagenesis analyses show that AH1 contributes to RNA
replication by affecting the biogenesis of DMVs making up the
membranous web. While we previously did not observe a direct
interaction of AH1 with cellular membranes [15], it is likely that
AH1 interacts with membranes when brought into the appropriate
context, e.g. in the presence of AH2 and/or upon oligomerization
of NS4B. AH1 may thereby influence membrane curvature
induction, resulting in proper DMV formation and assembly of a
functional replication complex. Indeed, membrane-associated
amphipathic a-helices flanked by positively charged residues have
been described to play a role in membrane curvature sensing [27]
(reviewed in [28]). As an example, Nath et al. recently
demonstrated that the autophagy regulator Atg3 possess an N-
terminal amphipathic a-helix which serves as membrane curva-
ture sensor [29]. Comparably to AH1, the Atg3 amphipathic a-
helix possesses two lysine residues (aa positions 9 and 11) bordering
a hydrophobic face devoid of aromatic aa residues. As we observed
DMVs of larger diameter in the AH1 mutant lacking at least one
lysine, we may hypothesize that NS4B AH1 plays a similar role in
membrane curvature sensing and induction. Hence, AH1 may
interact with the surface of a ‘‘pre-curved’’ membrane (large
DMVs), possibly induced by AH2 or another mechanism such as
NS4B oligomerization, and then further bend the membrane to
end up with smaller diameter DMVs competent for RNA
replication. Supporting this hypothesis, disruption of the hydro-
phobic face by introduction of charged residues, similar to the
Atg3 mutants described by Nath et al. [29], has previously been
shown to abrogate RNA replication [19].
The size and morphology of DMVs have been reported to affect
the replication of HCV and other positive-strand RNA viruses. In
this context, pharmacologic inhibition or silencing of phosphati-
dylinositol-4 kinase IIIa or of its effector oxysterol-binding protein,
both of which are required for HCV RNA replication, have been
shown to reduce DMV diameter [30,31]. A direct correlation
between altered DMV morphology and impaired RNA replication
has been demonstrated for mutations in the C-terminal part of
NS4B [24]. Mutations in murine hepatitis virus nonstructural
protein 4 have been reported to affect DMV morphology and
RNA replication [32] and mutations in equine arteritis virus
Table 1. Pseudoreversions selected with the NS4B K18A mutant.
Clone n6 NS3 NS4B1 NS5A
#12 T40I N62D
P189L
#2 Q26R
#3 Q22R P189L
#4 P44L P189L
#5 Y57H R214K P189L
#6 R25H P189L
L259F
#7 M39L P189L
#8 P189L
#9 Q27R K30T
K166R
P189L
1Mutations indicated in italic reside in AH1.
2Clone #1 has been identified twice by sequencing.
doi:10.1371/journal.ppat.1004501.t001
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Figure 6. Analysis of pseudorevertants selected with NS4B AH1 mutant K18A. (A) Selected amino acid changes identified following
transfection of a selectable subgenomic replicon harboring the NS4B AH1 K18A mutation (see Table 1) were reengineered into a subgenomic HCV
replicon harboring a luciferase reporter gene. In vitro transcribed RNAs were electroporated into Huh-7.5 cells, followed by luciferase activity
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nonstructural protein 3 have been shown to impair DMV
formation [33]. However, HCV mutants that increase the
diameter of DMVs have to our knowledge not been described
previously. Taken together, our observations and previous reports
indicate that a defined size and morphology of DMVs is required
for efficient viral RNA replication.
Selection for pseudoreversions and modeling in the three-
dimensional structure revealed that the two positively charged
residues flanking AH1 have to be located on opposite sides of the
a-helix for NS4B to be functional in HCV RNA replication. It is
possible that these residues stabilize electrostatic interactions with
the negatively charged phospholipid head groups in-plane of a
membrane surface. Analysis of pseudorevertants indicates that
laterally oriented positively charged side chains on either side of
the a-helix are required irrespective of their position along the
helix. However, the fact that the two lysine residues in aa positions
18 and 20 are conserved across all HCV isolates indicates that
viral fitness favors the presence of the positively charged residues at
these two specific positions. In keeping with our observations, a
mutagenesis study performed previously in a subgenomic replicon
derived from the Con1 strain (genotype 1b) identified an
important role for Lys 20, with pseudoreversion to positively
charged aa residues, i.e. lysine or arginine, at positions 15 or 16
[34].
Selection of aa changes in NS5A, some of which we show here
to partially rescue the defect of NS4B mutant K18A, point toward
functional interactions and a concerted action of NS4B and NS5A
in replication complex formation, as supported by recent EM
analyses of the membrane rearrangements induced by NS4B and
NS5A [13] as well as earlier work on the phosphorylation of NS5A
[35,36]. In our study, we have identified an NS5A P189L change
in 9 out of 10 sequenced clones. This aa change is located in
domain I of NS5A, in a surface-exposed position that has the
potential to interact with cytosolically oriented NS4B residue Lys
18 (not illustrated). However, it confers only a minor replication
advantage in the NS4B K18A mutant context. Similarly, in a
previous mutagenesis analysis of the C-terminal region of NS4B,
the NS5A K139E change has been identified in several clones
without conferring a major advantage for RNA replication on its
own but partially required in combination with other pseudor-
eversions in NS4B [24]. Further investigating the interaction
between NS4B and NS5A will in all likelihood reveal important
insight into the roles of NS4B in HCV RNA replication and likely
also virus production.
While the best known function of NS4B is its role in inducing
the membrane rearrangements required for HCV RNA replica-
tion, there is growing evidence that NS4B is also involved in virus
production [24,35,36]. The NS4B mutants described so far either
enhanced virus assembly [24,35] or decreased RNA encapsidation
[36] and were all localized in the C-terminal region of NS4B.
E8A/E15A is one of the first mutants reported to strongly decrease
virus production with almost unimpaired HCV RNA replication
capacity. Since intracellular virus titers are reduced to the same
extent as extracellular titers, assembly is likely affected in this
mutant. Given the evidence for functional interactions between
NS4B and NS5A as well as the critical role of NS5A in virus
assembly [37,38], we may hypothesize that AH1 mutant E8A/
E15A affects NS4B-NS5A interplay, thereby influencing virion
assembly. Future work investigating the role of NS4B in virus
production would be facilitated by the development of a
complementation system that allows to separate the functions of
NS4B in RNA replication and virus production.
A dual topology of the N terminus of NS4B has been suggested
earlier [16,17]. In line with these observations, we had previously
shown that AH2 has the potential to traverse the phospholipid
bilayer, likely upon oligomerization [15,18]. Here, we provide
evidence for a dual topology of the N-terminal part of NS4B in a
functional, replicative context. A working model for these two
topologies is illustrated in Figure 9. Based on its physicochemical
properties, we could envision a scenario where AH1 remains in the
ER lumen, possibly associated with the inner side of the ER
membrane, sensing its curvature, and bending the membrane
during membranous web formation. However, we believe that it is
unlikely that AH1 itself traverses the membrane so that an ER
luminal loop be formed between AH1 and AH2 (scenario
therefore not illustrated in Fig. 9). Indeed, AH1 appears not
hydrophobic enough to achieve a transmembrane topology and
there is no obvious interaction platform between multiple copies of
AH1 or AH1 and AH2 to yield a transmembrane hydrophobic
complex.
Given the limited coding capacity of viral genomes, many
encoded proteins have evolved to exert multiple functions. One
strategy to achieve multifunctionality may be topological changes
with respect of the membrane. In this context, the hepatitis B
virus large surface protein and the fusion protein of Newcastle
disease virus have been shown to adopt dual membrane
topologies with potentially different functions [39,40]. Based on
these observations, it is tempting to speculate that the different
topologies of NS4B may serve distinct functions in the HCV life
cycle. Clearly, future work will have to address this intriguing
possibility.
Materials and Methods
Sequence analyses and structure predictions
Sequence analyses were performed using the web-based tools
available at the European HCV Database (http://euhcvdb.ibcp.
fr/) [41] and the Network Protein Sequence Analysis (NPSA)
website of the Institut de Biologie et Chimie des Prote´ines (IBCP)
(http://npsa-pbil.ibcp.fr) [42]. Multiple sequence alignment and
analyses of aa conservation were carried out with the ClustalW
program using default parameters [43]. HeliQuest was used for a-
helix projections (www.heliquest.ipmc.cnrs.fr) [22].
Cell lines and reagents
Human hepatocellular carcinoma cell lines Huh-7.5 [44] (kindly
provided by Charles M. Rice, The Rockefeller University, New
York, NY) and Huh7-Lunet [25] were maintained in Dulbecco’s
modified Eagle medium supplemented with 10% fetal bovine
serum. The Huh-7-derived cell line H7-T7-IZ, which stably
expresses the T7 RNA polymerase, was maintained in the same
medium supplemented with 5 mg/ml zeocin [13]. Transfections
were performed by the use of polyethylenimine [45]. Monoclonal
antibodies (mAbs) C7-50 against HCV core [46], A4 against HCV
E1 [47] (kindly provided by Jean Dubuisson, University of Lille,
France), as well as 9E10 [48] against HCV NS5A (kindly provided
measurement at 4, 24, 48 and 72 h post-electroporation. Relative light units (RLU) were normalized to values measured at 4 h. Results from two
independent experiments were pooled (n = 8 for each construct and time point). For statistical analyses, RLU measured at 48 h were compared to the
48-h values obtained with mutant K18A. *, P,0.001. (B) Structure models of the different AH1 sequences were established by using Swiss-PdbViewer
4.01 software [69] and drawn by using VMD 1.9 software [68].
doi:10.1371/journal.ppat.1004501.g006
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by Charles M. Rice) have been described. MAb AC-15 against b-
actin was from Sigma-Aldrich. MAb HA-7 and polyclonal
antibody Y-11 against the HA tag were from Sigma-Aldrich and
Santa Cruz, respectively. Polyclonal antibody #86 against HCV
NS4B has been described [37]. Secondary antibodies were anti-
mouse-HRP (GE Healthcare), anti-rabbit-HRP (DAKO), Alexa
Fluor 488- and Alexa Fluor 594-conjugated anti-mouse IgG, as
well as Alexa Fluor 488-conjugated anti-rabbit IgG (Life
Technologies).
Plasmids
Plasmids pUHD15-1 (allowing expression of the tetracycline-
regulated transactivator tTA) [49] and pUHD-Cp7con (allowing
expression from a tTA-responsive promotor) were cotransfected to
express core-E1-E2-p7 derived from the HCV H77 (genotype 1a)
consensus clone [50], as described [51].
pFK-based plasmids pFK_Jc1_dg, pFK_Jc1DE1E2_dg, pFK-
i389-neo-sg-JFH1, pFK_i389LucNS3-39-NS4BHA31R_JFH_dg,
pFK_i389LucNS3-39_JFH_dg and the non-replicating control
construct pFK_i389LucNS3-39_NS5BDGDD_JFH_dg have been
described [14,52,53]. Plasmid pTM-NS3-39_JFH allows for the
T7 RNA polymerase-based expression of the HCV replicase
proteins (NS3 to NS5B) [23].
Subgenomic HCV JFH1 replicon constructs harboring a
bicistronic firefly luciferase reporter gene were based on
pFK_i389LucNS3-39_JFH_dg. Mutations K18A, K20A, K18A/
K20A, KASK and E8A/E15A were generated by two-step PCR
amplification using primers JFH1-5042-fd and AH1-K18A-rv,
AH1-K20A-rv, AH1-KKAA-rv, AH1-KASK-rv or AH1-EEAA-
rv, respectively (Table S2), followed by primers AH1-K18A-fd,
AH1-K20A-fd, AH1-KKAA-fd, AH1-KASK-fd or AH1-EEAA-
fd, respectively, and JFH1-7730-rv (Table S2). Final products were
amplified by overlap extension PCR using primers JFH1-5042-fd
and JFH1-7730-rv (Table S2), followed by cloning into the NsiI-
RsrII sites of pFK_i389LucNS3-39_JFH_dg, yielding constructs
Luc-JFH1-AH1_K18A, Luc-JFH1-AH1_K20A, Luc-JFH1-
AH1_K18A/K20A, Luc-JFH1-AH1_KASK and Luc-JFH1-
AH1_E8A/E15A.
Neomycin-selectable subgenomic HCV JFH1 replicon constructs
were generated by subcloning of the NsiI/BsrGI fragments from the
Luc-JFH1 constructs above into pFK_i389-neo-sg-JFH1, yielding
constructs Neo-JFH1-AH1_K18A, Neo-JFH1-AH1_K20A, Neo-
JFH1-AH1_K18A/K20A and Neo-JFH1-AH1_KASK.
Pseudorevertant constructs were generated in subgenomic HCV
JFH1 replicon constructs harboring a bicistronic firefly luciferase
reporter gene by two-step PCR amplification using primers JFH1-
5042-fd and JFH4BQ22R-rv or JFH4BQ26R-rv (Table S2) with
either pFK_i389LucNS3-39_JFH_dg (wild-type) or Luc-JFH1-
AH1_K18A as template, followed by amplification of pFK_i389-
LucNS3-39_JFH_dg (wild-type) or the corresponding sequence
harboring the NS5A K189L mutation using primers
JFH4BQ22R-fd or JFH4BQ26R-fd and JFH1-7730-rv (Table
S2). Final products were amplified by overlap extension PCR
using primers JFH1-5042-fd and JFH1-7730-rv (Table S2),
followed by cloning into the NsiI-RsrII sites of pFK_i389-
LucNS3-39_JFH_dg, yielding constructs Luc-JFH1-AH1_Q22R,
Luc-JFH1-AH1_Q26R, Luc-JFH1-AH1_K18A/Q22R, Luc-
JFH1-AH1_K18A-5A_K189L, Luc-JFH1-AH1_K18A/Q22R-
5A_K189L and Luc-JFH1-AH1_K18A/Q26R. Construct Luc-
JFH1-AH1_K18A/Q27R was generated by PCR using primers
JFH1-5042-fd and JFH1-7730-rv (Table S2), followed by the same
cloning strategy.
Jc1 full-length constructs were generated by subcloning of the
AvrII/RsrII fragments from the Luc-JFH1 constructs above into pFK-
Jc1_dg, yielding constructs Jc1-AH1_E8A/E15A, Jc1-AH1_K18A,
Jc1-AH1_K18A/Q22R, Jc1-AH1_Q26R and Jc1-AH1_K18A/
Q26R. Construct Jc1-DGDD was generated by subcloning of the
RsrII/SfiI from pFK_i389LucNS3-39_NS5BDGDD_JFH_dg into
pFK-Jc1_dg.
pTM-based constructs harboring NS4B mutations were generated
by subcloning of the NsiI/RsrII fragments from pFK_i389LucNS3-
39_JFH_dg or pFK_i389LucNS3-39-NS4BHA31R_JFH_dg into
pTM-NS3-39, yielding constructs pTM-NS3-39-AH1_K18A, pTM-
NS3-39-AH1_K20A, pTM-NS3-39-AH1_K18A/K20A, pTM-NS3-
39-AH1_E8A/E15A, and pTM-NS3-39-NS4BHA31R. Introduction
of NS4B mutations into pTM-NS3-39-NS4BHA31R was performed
by two-step PCR using primers JFH1-5042-fd and AH1-KKAA-rv
or AH1-EEAA-rv, followed by primers AH1-KKAA-fd or AH1-
EEAA-fd and JFH1-7730-rv. Final overlap extension PCR was
carried out with primers JFH1-5042-fd and JFH1-7730-rv, followed
by cloning into the NsiI-RsrII sites of pTM-NS3-39, yielding
constructs pTM-NS3-39-NS4BHA31R-AH1_K18A/K20A and
pTM-NS3-39-NS4BHA31R-AH1_E8A/E15A.
All contructs were verified by sequencing.
Figure 7. Alanine substitution of the conserved acidic residues
on the hydrophilic side of NS4B AH1 affects virus production.
(A) Extra- and intracellular infectivity after electroporation of a
replication-deficient (DGDD), wild-type (wt), E8A/E15A mutant and
envelope glycoprotein-deficient (DE1E2) full-length Jc1 genomes was
determined by 50% tissue culture infective dose (TCID50) measurement
at 48 h post-electroporation. (B) Intra- and extracellular HCV RNA levels
were determined by RT-PCR 48 h post-electroporation and normalized
to GAPDH mRNA level. Results measured for the wt were set to 100%.
Note the use of a linear scale as opposed to the logarithmic scale used
in panel A.
doi:10.1371/journal.ppat.1004501.g007
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In vitro transcription, electroporation, transient
replication and infection assays
In vitro transcription of subgenomic replicon and full-length
HCV RNA as well as electroporation were performed as
described ([54] and references therein). RNA replication assay
using a JFH1 subgenomic replicon harboring the firefly
luciferase as reporter was performed as described previously
[53,55]. Jc1 virus was produced as described [56]. TCID50 was
determined as described [48]. For the determination of
intracellular infectivity, cells were harvested and subjected to
three freeze and thaw cycles, followed by removal of debris by
centrifugation for 2 min at 11,0006 g before TCID50
determination.
Immunoblot
Protein lysates were prepared and subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed
by immunoblot analysis as described previously [57].
Figure 8. The N-terminal part of NS4B assumes a dual topology in a replicative context. (A) Huh7-Lunet cells harboring a subgenomic
HCV JFH1 replicon with an HA tag inserted between NS4B AH1 and AH2 (see Materials and Methods section) were subjected to total (0.2% digitonin
[Dig 0.2%], upper row) or selective membrane permeabilization (0.05% digitonin [Dig 0.05%], lower row), as described in the Materials and Methods
section. As a control, replicon cells were transfected with a CMV promotor-driven core-E1-E2-p7 expression construct. Core and NS5A served as
controls for cytosolically oriented proteins, E1 as a control for a luminally oriented protein. Monoclonal antibodies C7-50 against HCV core, A4 against
E1, 9E10 against NS5A, and HA-7 against the HA tag were used, followed by anti-mouse IgG Alexa Fluor 488 as secondary antibody. Images were
acquired on a confocal laser scanning microscope with the same settings for each antibody and condition. Analogous results were obtained when
polyclonal antibody Y-11 against the HA tag was used instead of monoclonal antibody HA-7. (B) Histogram of the fluorescence intensity ratios
between selective and total membrane permeabilization conditions. Fluorescence intensities in 10–60 images for each condition were determined by
using ImageJ software [70]. (C) H7-T7-IZ cells were transfected with a CMV promotor-driven core-E1-E2-p7 expression construct or T7 RNA
polymerase-driven N3-5B polyprotein expression constructs harboring the different mutations in HA-tagged NS4B, followed by selective membrane
permeabilization and immunofluorescence microscopy using the same antibodies as in panel A. Fluorescence intensity ratios between selective and
total membrane permeabilization conditions were determined as in panel B. AH2mut is a previously described mutant harboring alanine substitution
of 6 aromatic amino acid residues in NS4B AH2 [15]. This mutant is unable to translocate AH2 through the membrane bilayer. * P#0.0001; ns, non
significant (P.0.25).
doi:10.1371/journal.ppat.1004501.g008
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Peptide synthesis and purification
Peptide NS4B[1–40] from the HCV strain JFH-1 (accession
number AB047639; aa sequence reported in Fig. 2) was synthe-
sized on a Milligen 9050 apparatus, employing N-[9-fluorenyl]-
methoxycarbonyl (Fmoc) chemistry. The peptide was highly
purified by reversed-phase high-performance liquid chromatogra-
phy on a Nucleosil C18 column (120 A˚, 5 mm, 250 mm) using a
water-acetonitrile gradient containing 0.1% trifluoroacetic acid.
The peptide was eluted as a single peak at 65% acetonitrile and
identified by mass spectroscopy at its expected molecular mass.
Circular dichroism
Far UV CD spectra were recorded on a Chirascan spectrometer
(Applied Photophysics) calibrated with 1S-(+)-10-camphorsulfonic
acid. Measurements were carried out at 298 K in a 0.1-cm path
length quartz cuvette. Spectra were measured in a 180–260 nm
wavelength range with an increment of 0.2 nm, bandpass of
0.5 nm and integration time of 1 s. Spectra were processed,
baseline corrected, smoothed and converted with the Chirascan
software. Spectral units were expressed as the mean molar
ellipticity per residue by using the peptide concentration deter-
mined knowing the weighted NS4B[1–40] peptide used to prepare
the NMR sample. Estimation of the secondary structure content
was carried out on the DICHROWEB server (http://www.cryst.
bbk.ac.uk/cdweb/) [58].
NMR spectroscopy
Purified NS4B[1–40] peptide was dissolved in a mixture of 50%
TFE-d2 (.99%) in H2O (v/v), and 2,2-dimethyl-2-silapentane-5-
sulfonate was added to the NMR samples as an internal 1H
chemical shift reference. Multidimensional experiments were
performed at 25uC on a Bruker Avance 500 MHz spectrometer
using standard homonuclear pulse sequences, including nuclear
Overhauser enhancement spectroscopy (NOESY) (mixing times
between 100 and 250 ms) and clean total correlation spectroscopy
(TOCSY) (isotropic mixing time of 80 ms), as detailed previously
[59,60]. Water suppression was achieved by pre-saturation. Bruker
Topspin software was used to process all data and Sparky was used
for spectral analysis (http://www.cgl.ucsf.edu/home/sparky/).
Intra-residue backbone resonances and aliphatic side chains were
Figure 9. Dual membrane topology of HCV NS4B. The N-terminal part of NS4B assumes a dual membrane topology. Cartoons illustrating the
(A) cytosolic and the (B) luminal endoplasmic reticulum (ER) membrane topology of the N-terminal part of NS4B are shown. TMs, predicted
transmembrane segments.
doi:10.1371/journal.ppat.1004501.g009
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identified from homonuclear 1H TOCSY experiments and
confirmed with 1H-13C heteronuclear single quantum correlation
(HSQC) experiments in 13C natural abundance. Sequential
assignments were determined by correlating intra-residue assign-
ments with inter-residue cross peaks observed in bi-dimensional
1H NOESY. NMR-derived 1Ha and 13Ca chemical shifts are
reported relative to the random coil chemical shifts in TFE [61].
NMR-derived constraints and structure calculation
NOE intensities used as input for structure calculations were
obtained from the NOESY spectrum recorded with a 150 ms
mixing time and checked for spin diffusion on spectra recorded
at lower mixing times (50 ms). NOEs were partitioned into three
categories of intensities that were converted into distances
ranging from a common lower limit of 1.8 A˚ to upper limits of
2.8, 3.9 and 5.0 A˚, respectively. Protons without stereospecific
assignments were treated as pseudoatoms, and the correction
factors were added to the upper distance constraints [62].
Additionally, dihedral angle constraints calculated with Talos
[63] from 1H and 13C chemical shifts were introduced. Three-
dimensional structures were generated from NOE distances with
the standard torsion angle molecular dynamics protocol in the
XPLOR-NIH 2.30 program [64] using the standard force fields
and default parameter sets. A set of 50 structures was initially
calculated to widely sample the conformational space, and the
structures of low energy with no distance restraint violations
(.0.5 A˚) were retained. The selected structures were compared
by pairwise root-mean square deviation (RMSD) over the
backbone atom coordinates (N, Ca and C9). Local analogies
were analyzed by calculating the local RMSD of a tripeptide
window sliding along the sequence. Statistical analyses, super-
imposition of structures and structural analyses were performed
with MOLMOL [65] and the PDB Protein Structure Validation
Suite.
Selection for pseudorevertants, amplification of HCV RNA
by RT-PCR, and sequence analyses
Huh-7.5 cells were electroporated with 1 mg in vitro transcribed
RNA from neomycin-selectable subgenomic replicon constructs.
Electroporated cells were resuspended in 10 ml of medium,
followed by seeding of 10 ml, 100 ml or 1 ml into 10-cm tissue
culture dishes. After 24 h, G418 was added at a concentration of
500 mg/ml and maintained until single cell clones became visible.
Total RNA was extracted from pooled clones by using the RNeasy
Mini Kit (Qiagen) according to the manufacturer’s instructions.
One mg total RNA was reverse transcribed with specific anchor
primer JFH1-9442-rv, followed by PCR amplification using
primers EMCV-fd and JFH1-9442-rv using PfuTurbo DNA
Polymerase (Stratagene). Amplicons were cloned with Zero Blunt
TOPO PCR Cloning Kit (Life Technologies), followed by
sequencing of 10 clones.
Quantitative RT-PCR
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and
HCV RNA levels were measured by SYBR green real-time
PCR, as described [55].
Selective permeabilization
H7-T7-IZ or Huh7-Lunet replicon cells were seeded onto glass
coverslips. H7-T7-IZ cells were transfected 24 h later with pTM-
NS3-39 plasmids or with pUHD15-1 and pUHD-Cp7, allowing
expression of the HCV core-p7 region. Twenty-four h post-
transfection cells were fixed with 2% paraformaldehyde (Sigma-
Aldrich) for 10 min and then permeabilized for 15 min at 4uC
either by 0.2% or 0.05% digitonin (Sigma-Aldrich). Indirect
immunofluorescence was performed as described previously [57].
Slides were viewed on a Leica SP5 confocal laser scanning
microscope.
Electron microscopy
Huh7-Lunet T7 cells were seeded onto glass coverslips. On the
next day the cells were transfected with pTM-NS3-39-based
expression vectors by using the TransIT-LT1 transfection reagent
(Mirus Bio). After 24 h the cells were washed three times with
prewarmed PBS, fixed and processed for EM as described
previously [24]. Specimens were examined with a Zeiss EM 10
transmission electron microscope at 60 kV.
Statistical analyses
Significance values were calculated by using the unpaired t test
with the GraphPad Prism 6 software package (GraphPad
Software).
Accession numbers
The atomic coordinates for the NMR structure of synthetic
peptide NS4B[1–40] and the corresponding NMR restraints in
50% TFE are available in the Research Collaboratory for
Structural Bioinformatics (RCSB) Protein Data Bank under
accession number 2LVG (RCSB identification code 102881).
The chemical shifts of NS4B[1–40] residues have been deposited
in the BioMagResBank (BMRB) under the accession number
18568.
Supporting Information
Table S1 Statistics of final set of structures of NS4B[1–
40].
(DOCX)
Table S2 Oligonucleotide sequences.
(DOCX)
Figure S1 Amino acid sequence and superimposition of
the backbone heavy atoms (N, Ca, and C9) of the final set
of 37 calculated structures for the best overlap of
residues (PDB entry 2LVG). This Figure shows that the a-
helix is clearly defined between residues Ala 4 and Ala 32 (box),
but with an RMSD of 2.1 A˚ (see Table S1).
(DOCX)
Figure S2 H7-T7-IZ cells were transfected with T7 RNA
polymerase-driven N3-5B polyprotein expression con-
structs harboring the indicated mutations in HA-tagged
NS4B, followed by selective membrane permeabiliza-
tion and immunofluorescence microscopy. Cells were
subjected to total (0.2% digitonin [Dig 0.2%], upper row) or
selective membrane permeabilization (0.05% digitonin [Dig
0.05%], lower row), as described in the Materials and Methods
section. Representative pictures for wild-type (wt) and the different
mutants are shown.
(DOCX)
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